Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACH 2: Prophylactic Levetiracetam in Acute Intracerebral Haemorrhage
NCT07336992Phase 3Not yet recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2026
- Primary completion
- Apr 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levetiracetam in intracerebral hemorrhage (ICH), sponsored by Hospices Civils de Lyon. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
levetiracetam
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07336992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07336992.